Max Jonson
Director of Finance/CFO at BURE EQUITY AB
Net worth: 814 094 $ as of 2024-03-30
Profile
Max Jonson is currently a Director at BioLamina AB, Bure Growth AB, Skanditek AB, and Yubico AB.
He is also the Chief Financial Officer at Bure Equity AB and Bure Equity (Private Equity).
In the past, he worked as a Director at Celemiab Group AB, Dipylon Medical AB, and Celemi International AB.
He was also an Associate Director-Corporate Finance at SEB Group (Sweden) and a Finance Manager at Dpnova AB.
Additionally, he served as the Chief Financial Officer at Orasolv AB, Stockholm School of Economics Ifl, and SSE Executive Education.
Mr. Jonson holds an MBA from The University of Chicago and an undergraduate degree from New York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BURE EQUITY AB
0.02% | 2023-06-18 | 14,829 ( 0.02% ) | 475 411 $ | 2024-03-30 |
YUBICO AB
0.02% | 2022-12-30 | 19,000 ( 0.02% ) | 338 683 $ | 2024-03-30 |
Max Jonson active positions
| Companies | Position | Start |
|---|---|---|
| BURE EQUITY AB | Director of Finance/CFO | 2013-09-30 |
| Skanditek AB | Director/Board Member | - |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Director/Board Member | - |
Bure Growth AB
 Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Bure Equity (Private Equity)
 Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Director of Finance/CFO | 2013-08-31 |
Former positions of Max Jonson
| Companies | Position | End |
|---|---|---|
| Celemi International AB | Director/Board Member | 2017-12-31 |
Dipylon Medical AB
 Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Director/Board Member | 2016-12-31 |
Celemiab Group AB
 Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Director/Board Member | 2015-12-31 |
| Sse Executive Education | Director of Finance/CFO | 2012-12-31 |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Max Jonson
| The University of Chicago | Masters Business Admin |
| New York University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BURE EQUITY AB | Finance |
| YUBICO AB | Distribution Services |
| Private companies | 13 |
|---|---|
Orasolv AB
 Orasolv AB Medical/Nursing ServicesHealth Services Orasolv AB engages in the provision of dental care. It acquires, develops, and manages practices within the dental sector, as well as delivers consultancy services to Swedish dentists. The firm also operates a chain of dental clinics. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Health Services |
Bure Equity (Private Equity)
Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Finance |
Celemiab Group AB
Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Commercial Services |
Dpnova AB
 Dpnova AB Medical/Nursing ServicesHealth Services DPNOVA, headquartered in Malmö, is the leading dental laboratory in Sweden with over 207 MSEK in revenue over 250 employees across five locations (Malmö, Stockholm, Göteborg, Sjöbo, and Jönköping). Started in 1950, DPNOVA delivers a full range of dental lab services to dentists. | Health Services |
Dipylon Medical AB
Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Health Technology |
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
| Atle Investment Management AB | |
Bure Growth AB
Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Finance |
| Celemi International AB | |
| SEB Group (Sweden) | |
ACQ Bure AB
 ACQ Bure AB Financial ConglomeratesFinance ACQ Bure AB is a non-operational acquisition company. Its investment strategy is to identify and complete an acquisition of a company that can create value for the shareholders over time. The company was founded on October 26, 2020 and is headquartered in Stockholm, Sweden. | Finance |
| Skanditek AB | |
| Sse Executive Education |
- Stock Market
- Insiders
- Max Jonson
